RedHill Biopharma Ltd. (NASDAQ:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that Mr. Adi Frish, RedHill’s Chief Corporate & Business Development Officer, will present a corporate overview at the BIO-Europe Digital Conference, taking place October 25-28, 2021.
The presentation will be available on-demand for 30 days on the Company’s website from the start of the conference: https://www.redhillbio.com/investors.